This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Regeneron Pharmaceuticals, Inc.. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: The Innovations of Isabelle Livigni
Introduction
Isabelle Livigni is an accomplished inventor based in New York, NY (US). She has made significant contributions to the field of biotechnology, particularly in the development of methods for preparing polypeptides. Her innovative work has led to the filing of a patent that showcases her expertise and dedication to advancing scientific knowledge.
Latest Patents
Isabelle holds a patent for "Systems and methods for preparing a polypeptide from a mixture." This patent outlines methods for preparing a target polypeptide from a mixture that includes the target polypeptide. The method involves contacting the mixture with a hydrophobic interaction chromatography (HIC) apparatus that consists of multiple chromatographic zones. The process includes passing the target polypeptide through the outlets of at least a first zone and a second zone of the HIC apparatus. Notably, the residence time for the mixture in the first zone is approximately the same as that of one or more mobile phases in the second zone. Isabelle has 1 patent to her name.
Career Highlights
Isabelle is currently employed at Regeneron Pharmaceuticals, Inc., where she continues to contribute to groundbreaking research and development in the pharmaceutical industry. Her work at Regeneron has positioned her as a key player in the advancement of therapeutic solutions.
Collaborations
Isabelle collaborates with talented professionals in her field, including her coworkers Stefanie McDermott and James Reilly. These collaborations enhance the innovative environment at Regeneron and contribute to the success of their projects.
Conclusion
Isabelle Livigni's contributions to biotechnology through her patent and work at Regeneron Pharmaceuticals, Inc. highlight her role as a leading inventor in her field. Her innovative methods for preparing polypeptides demonstrate her commitment to advancing scientific research and development.
